The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Recurrence score and quantitative ER expression to predict in late distant recurrence risk in ER+ BC after 5 years of tamoxifen.
Norman Wolmark
No relevant relationships to disclose
Eleftherios P Mamounas
No relevant relationships to disclose
Frederick L. Baehner
Employment or Leadership Position - Genomic Health (I); Genomic Health
Stock Ownership - Genomic Health (B)
Steven M. Butler
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Gong Tang
No relevant relationships to disclose
Farid Jamshidian
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Amy P. Sing
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Steven Shak
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Soonmyung Paik
No relevant relationships to disclose